| scholarly article | Q13442814 |
| P2093 | author name string | Jean-Jacques Risso | |
| Laurent Chazalviel | |||
| Marc Lemaire | |||
| Christophe Rouillon | |||
| Hélène N David | |||
| Jacques H Abraini | |||
| Benoit Haelewyn | |||
| Gabriela Apiou | |||
| Myriam Lecoq | |||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | xenon | Q1106 |
| cerebral infarction | Q1209150 | ||
| P304 | page(s) | 1275-1286 | |
| P577 | publication date | 2007-11-16 | |
| P1433 | published in | FASEB Journal | Q520194 |
| P1476 | title | Neuroprotective effects of xenon: a therapeutic window of opportunity in rats subjected to transient cerebral ischemia | |
| P478 | volume | 22 |
| Q43733724 | A method for calculating the gas volume proportions and inhalation temperature of inert gas mixtures allowing reaching normothermic or hypothermic target body temperature in the awake rat. |
| Q36765480 | A randomized trial of the effects of the noble gases helium and argon on neuroprotection in a rodent cardiac arrest model. |
| Q47737570 | Adding 5 h delayed xenon to delayed hypothermia treatment improves long-term function in neonatal rats surviving to adulthood |
| Q34734811 | Advances in emerging nondrug therapies for acute stroke 2007. |
| Q33713070 | Anaesthetic-related neuroprotection: intravenous or inhalational agents? |
| Q35595815 | Application of medical gases in the field of neurobiology |
| Q40761247 | Argon blocks the expression of locomotor sensitization to amphetamine through antagonism at the vesicular monoamine transporter-2 and mu-opioid receptor in the nucleus accumbens. |
| Q34987735 | Argon prevents the development of locomotor sensitization to amphetamine and amphetamine-induced changes in mu opioid receptor in the nucleus accumbens. |
| Q30426331 | Argon: systematic review on neuro- and organoprotective properties of an "inert" gas. |
| Q91651212 | Beneficial effects of xenon inhalation on behavioral changes in a valproic acid-induced model of autism in rats |
| Q48366149 | Catuaba (Trichilia catigua) prevents against oxidative damage induced by in vitro ischemia-reperfusion in rat hippocampal slices |
| Q47930576 | Delayed post-ischaemic administration of xenon reduces brain damage in a rat model of global ischaemia. |
| Q55413869 | Delayed xenon post-conditioning mitigates spinal cord ischemia/reperfusion injury in rabbits by regulating microglial activation and inflammatory factors. |
| Q39097123 | Early treatment with xenon protects against the cold ischemia associated with chronic allograft nephropathy in rats |
| Q55092215 | Effects of Therapeutic Hypothermia Combined with Other Neuroprotective Strategies on Ischemic Stroke: Review of Evidence. |
| Q42368537 | Effects of normobaric versus hyperbaric oxygen on cell injury induced by oxygen and glucose deprivation in acute brain slices |
| Q28481156 | Ex vivo and in vivo neuroprotection induced by argon when given after an excitotoxic or ischemic insult |
| Q34232974 | Factors related to executive dysfunction after acute infarct |
| Q48327132 | Gas chromatography/mass spectrometry measurement of xenon in gas-loaded liposomes for neuroprotective applications |
| Q41930720 | Human recombinant tissue-plasminogen activator (alteplase): why not use the 'human' dose for stroke studies in rats? |
| Q59134386 | Is xenon a future neuroprotectant? |
| Q47435018 | Mapping Hydrophobic Tunnels and Cavities in Neuroglobin with Noble Gas under Pressure |
| Q90715151 | Massive in Silico Study of Noble Gas Binding to the Structural Proteome |
| Q35321053 | Moderately delayed post-insult treatment with normobaric hyperoxia reduces excitotoxin-induced neuronal degeneration but increases ischemia-induced brain damage |
| Q44720912 | Modulation by the noble gas argon of the catalytic and thrombolytic efficiency of tissue plasminogen activator |
| Q26782756 | Neuroprotective Strategies after Neonatal Hypoxic Ischemic Encephalopathy |
| Q42720751 | Neutrophils generate microparticles during exposure to inert gases due to cytoskeletal oxidative stress |
| Q37981711 | New pharmacologic and therapeutic approaches for hypoxic-ischemic encephalopathy in the newborn |
| Q26768557 | Peptidylarginine Deiminases as Drug Targets in Neonatal Hypoxic-Ischemic Encephalopathy |
| Q48650551 | Post-ischemic helium provides neuroprotection in rats subjected to middle cerebral artery occlusion-induced ischemia by producing hypothermia |
| Q57492270 | Potential application value of xenon in stroke treatment |
| Q33765349 | RODENT STROKE MODEL GUIDELINES FOR PRECLINICAL STROKE TRIALS (1ST EDITION). |
| Q35872374 | Refined Qingkailing Protects MCAO Mice from Endoplasmic Reticulum Stress-Induced Apoptosis with a Broad Time Window |
| Q38221454 | Saturation diving; physiology and pathophysiology |
| Q94400422 | Stem cell‐based interventions for the prevention of morbidity and mortality following hypoxic‐ischaemic encephalopathy in newborn infants |
| Q35933917 | Structural Basis for Xenon Inhibition in a Cationic Pentameric Ligand-Gated Ion Channel |
| Q33943360 | Synergistic neuroprotective therapies with hypothermia |
| Q52149911 | Temporal Changes in Caspase-1 and Caspase-8 Activities Following Brain Hypoxia With and Without Src kinase Inhibition in a Piglet Animal Model. |
| Q28066452 | The Molecular Pathway of Argon-Mediated Neuroprotection |
| Q38842550 | The noble gas xenon provides protection and trophic stimulation to midbrain dopamine neurons |
| Q37036178 | Therapeutic antioxidant medical gas. |
| Q34570042 | XENON in medical area: emphasis on neuroprotection in hypoxia and anesthesia |
| Q40428767 | Xenon Blocks Neuronal Injury Associated with Decompression |
| Q36037682 | Xenon Combined with Therapeutic Hypothermia Is Not Neuroprotective after Severe Hypoxia-Ischemia in Neonatal Rats |
| Q41494217 | Xenon for tunnelling analysis of the efflux pump component OprN. |
| Q33864434 | Xenon inhibits excitatory but not inhibitory transmission in rat spinal cord dorsal horn neurons |
| Q39908525 | Xenon is an inhibitor of tissue-plasminogen activator: adverse and beneficial effects in a rat model of thromboembolic stroke |
| Q46928898 | Xenon-helium gas mixture at equimolar concentration of 37.5% protects against oxygen and glucose deprivation-induced injury and inhibits tissue plasminogen activator |
Search more.